Structure/class |
- Cardiac glycoside
|
Pharmacodynamics |
- It is an inhibitor of Na+/K+ ATP-ase.
- Therefore – this increases intracellular Na+ and decreased intracellular K+.
- Because of increased intracellular Na+, there is reduced Na/Ca exchanger activity and therefore, there is an increase in intracellular calcium.
- This increase in intracellular Ca2+ causes an increase in contractility.
- Electrical effects
- At higher concentrations of digitalis, a relative extracellular hyperkalemia and intracellular hypercalcaemia occurs.
- This leads to increased automaticity of the heart muscle (easier for the myocyte to reach threshold potential). Therefore, there are patterns of bigeminy, followed by VT and then VF.
- Parasympathetic and sympathetic effects
- At lower doses, digoxin has parasympathetic effects: early signs of toxicity are bradycardia and AV block. At higher doses of toxicity, there is an increased sympathetic effect which may further sensitize the myocardium to automaticity.
- Other system effects
- GIT: it excites the GIT tissues, so patients develop anorexia/nausea/vomiting/diarrhea.
- CNS: disorientation and visual hallucinations may be present.
|
Absorption/Administration |
|
Distribution |
- It has a large Vd à 6.3L/kg. This allows it to enter the CNS. It accumulates in the heart, kidney and liver.
|
Metabolism |
- Less than 20% is metabolized.
|
Excretion |
- Mostly excreted unchanged in kidneys (And therefore, needs dose adjustment in renal failure). Its T ½ is 40 hours.
|
Indications |
- AF, especially in the setting of heart failure.
|
Contraindications |
|
Special precautions |
- Renal failure
- Hyperkalemia
- Hypothyroidism
|
Interactions |
- Electrolytes
- Hyperkalemia – hyperkalemia inhibits digoxin binding to the Na/K ATP-ase. Hyperkalemia itself also reduces cardiac automaticity. Therefore, moderate hyperkalemia will reduce the toxicity of digoxin.
- Hypercalcaemia – potentiates digoxin toxicity by increasing the intracellular Ca2+ stores, producing automaticity.
- Hypermagnesemia – opposite effect to hypercalcaemia.
- Drugs that increase digoxin effect
- Amiodarone (by increasing plasma digoxin concentrate), diltiazem, verapamil, quinidine, macrolide antibiotics (azithromycin, erythromycin and clarithromycin), K+ depleting drugs (including diuretics), spironolactone and propafenone.
- Drugs that decrease digoxin effect
- Kaolin pectin, rifampicin (by increasing metabolism) and sulfasalazine (by decreasing GI absorption)
|
Adverse events |
- As mentioned above
|
Dosing/administration |
|
Toxicology |
- Symptoms as mentioned above.
- Specific antidote is DigiFab antibody, where 1 vial (40mg) binds to ~0.5mg digoxin.
|
Withdrawal syndrome |
|
Special notes |
|